InMed Pharmaceuticals Inc. (INM)

NASDAQ: INM · IEX Real-Time Price · USD

0.235

-0.018 (-7.27%)

At close: Apr 26, 2024, 3:59 PM

0.245

+0.010 (4.39%)

After-hours: Apr 26, 2024, 4:15 PM EDT

InMed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	8.91	6.18	7.36	5.81	9.84
Short-Term Investments	0.04	0.04	0.05	0.04	3.95
Cash & Cash Equivalents	8.96	6.22	7.41	5.85	13.78
Cash Growth	43.96%	-16.03%	26.70%	-57.57%	-
Receivables	0.26	0.09	0.01	0.05	0.06
Inventory	1.62	2.49	0	0	0
Other Current Assets	0.5	0.8	0.96	0.42	0.32
Total Current Assets	11.33	9.6	8.38	6.31	14.17
Property, Plant & Equipment	0.72	0.9	0.33	0.4	0.04
Goodwill and Intangibles	1.95	2.11	1.06	1.09	1.22
Other Long-Term Assets	0.1	0.18	0.01	0	0
Total Long-Term Assets	2.77	3.19	1.4	1.49	1.26
Total Assets	14.11	12.79	9.78	7.8	15.44
Accounts Payable	1.61	2.92	2.13	1.61	1.19
Current Debt	0.38	0.4	0.08	0.07	0
Other Current Liabilities	0.02	0	0	0	0
Total Current Liabilities	2	3.32	2.22	1.68	1.19
Long-Term Debt	0	0	0.19	0.25	0
Other Long-Term Liabilities	0.02	0.39	0	0	0
Total Long-Term Liabilities	0.02	0.39	0.19	0.25	0
Total Liabilities	2.02	3.71	2.4	1.92	1.19
Total Debt	0.38	0.4	0.27	0.32	0
Debt Growth	-7.07%	49.86%	-14.89%	-	-
Retained Earnings	-101.4	-93.45	-74.85	-64.65	-55.71
Comprehensive Income	0.13	0.13	0.13	-0.3	0.12
Shareholders' Equity	12.09	9.08	7.38	5.88	14.24
Net Cash / Debt	8.58	5.82	7.14	5.53	13.78
Net Cash / Debt Growth	47.51%	-18.52%	29.08%	-59.87%	-
Net Cash Per Share	3.50	10.37	26.56	26.49	66.37
Working Capital	9.33	6.28	6.16	4.64	12.98
Book Value Per Share	4.94	16.19	27.44	28.15	68.58

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).